Rapid scaling-up of antiretroviral therapy in 10 000 adults in Côte d'Ivoire: 2-year outcomes and determinants

Toure, Siaka; Kouadio, Bertin; Seyler, Catherine; More

AIDS . 22(7):873-882, April 23, 2008.

Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa

Seyler, Catherine; Adjé-Touré, Christiane; Messou, Eugène; More

AIDS . 21(9):1157-1164, May 31, 2007.

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d’Ivoire: a trial-based analysis

Yazdanpanah, Yazdan; Losina, Elena; Anglaret, Xavier; More

AIDS . 19(12):1299-1308, August 12, 2005.

Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire

Anglaret, Xavier; Messou, Eugène; Ouassa, Timothée; More

AIDS . 17(4):575-584, March 7, 2003.

Effect of early chemoprophylaxis with co-trimoxazole on nutritional status evolution in HIV-1-infected adults in Abidjan, Côte d'Ivoire

Castetbon, Katia; Anglaret, Xavier; Attia, Alain; More

AIDS . 15(7):869-876, May 4, 2001.